The company have significantly improved this course of a new treatment for amyloid heart disease, employing the investigational drug. Early trial data suggests significant benefits for individuals diagnosed by this https://attr-cm866826.full-design.com/bridgebio-advances-attr-cm-management-through-the-drug-84772288